Rick Pauls | President & CEO |
Scott Kellen | CFO |
Harry Alcorn | Chief Medical Officer |
Alex Nowak | Craig-Hallum |
Etzer Darout | Guggenheim |
Elemer Piros | ROTH Capital Partners |
Thomas Flaten | Lake Street Capital Markets |
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Fourth Quarter 2020 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor Relation section.
Before the company proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements. More information, including factors that could cause actual results to differ from projected results appears in the including factors that cause actual results.